Cisco Systems' $28 billion acquisition of Splunk 'went much faster than we thought'
By Jon Swartz
Company is enhancing its software business and striving to offset a postpandemic slowdown in demand
Cisco Systems Inc. on Monday completed its $28 billion acquisition of Splunk Inc. "much faster than we thought," Cisco Chief Financial Officer Scott Herren said in an interview.
"It is a testament to good work by both companies and nice synergies with not a lot of overlap," Herren said. The deal was announced in September.
Cisco said Splunk's (SPLK) security capabilities, combined with Cisco's (CSCO) scale network and security, "will provide leading security analytics and coverage from devices to applications to clouds," Cisco Chief Executive Officer Chuck Robbins said in a statement. The joint collaboration, he said, "will drive the next generation of AI-enabled security and observability."
Last week, Cisco won unconditional European Union antitrust approval for the deal, the company's biggest ever, as it enhances its software business during a boom in artificial intelligence and strives to offset a postpandemic slowdown in demand.
-Jon Swartz
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-18-24 1123ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise